Vivos Therapeutics Receives Notice Of Allowance For US Patent Application 18/215,930 Titled "Vibrational Oral Appliance With Mandibular Advancements For Temporary Relief From Sleep Disordered Breathing, Sleep Apnea, And/Or Snoring"
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has received a Notice of Allowance for its US Patent Application 18/215,930, which covers a vibrational oral appliance designed to provide temporary relief from sleep disordered breathing, sleep apnea, and snoring.
July 23, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vivos Therapeutics has received a Notice of Allowance for its US Patent Application 18/215,930, which covers a vibrational oral appliance designed to provide temporary relief from sleep disordered breathing, sleep apnea, and snoring.
The Notice of Allowance for the patent application is a positive development for Vivos Therapeutics as it strengthens their intellectual property portfolio and could lead to new product offerings. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100